Crossmark

Comparing the effectiveness of agomelatine, bupropion, and sertraline in the treatment of non-psychotic major depressive disorder: a double- blind, randomized clinical trial

Crossref DOI link: https://doi.org/10.1016/j.psiq.2025.100742

Published Print: 2025-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Hamzehpour, Romina

Ahangar, Ashraf

Alamouti, Elham Motevalli

Khierkhah, Farzan

Khoozan, Mahboobeh

Shirafkan, Hoda
License Information

Text and Data Mining valid from 2025-10-01

Text and Data Mining valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01

stm-asf valid from 2025-10-01
More Information

This article is maintained by: Elsevier

Article Title: Comparing the effectiveness of agomelatine, bupropion, and sertraline in the treatment of non-psychotic major depressive disorder: a double- blind, randomized clinical trial

Journal Title: Psiquiatría Biológica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.psiq.2025.100742

Content Type: article

Copyright: © 2025 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below